MetaADEDB 2.0 @ LMMD
Nystatin and triamcinolone acetonide
(PFADFVCWHVCPLV-QRPSVTLHSA-N)
Structure
SMILES
O[C@@H]1CC[C@@H](O)[C@H](O)CC2(O)C[C@H](O)[C@H]([C@@H](O2)C[C@H](/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@@H]([C@H]([C@H]([C@@H](OC(=O)C[C@@H](C[C@@H](C1)O)O)C)C)O)C)O[C@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)N)O)C(=O)O.OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1CCC1=CC(=O)C=C[C@]21C)F)(C)C
Molecular Formula:
C71H106FNO23
Molecular Weight:
1360.590
Log P:
4.0548
Hydrogen Bond Acceptor:
24
Hydrogen Bond Donor:
14
TPSA:
412.67
CAS Number(s):
155961-51-6
Synonym(s)
1.
Nystatin and triamcinolone acetonide
External Link(s)
PubChem Compound129316490
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 8US FAERS
2Burning sensationFAERS: 3US FAERS
3PruritusFAERS: 3US FAERS
4Application site irritationFAERS: 2US FAERS
5Application site painFAERS: 2US FAERS
6DizzinessFAERS: 2US FAERS
7Drug effective for unapproved indicationFAERS: 2US FAERS
8Drug ineffective for unapproved indicationFAERS: 2US FAERS
9HeadacheFAERS: 2US FAERS
10Product label issueFAERS: 2US FAERS
11Wrong technique in product usage processFAERS: 2US FAERS
12Accidental exposure to productFAERS: 1US FAERS
13Activities of daily living impairedFAERS: 1US FAERS
14Application site erythemaFAERS: 1US FAERS
15Application site pruritusFAERS: 1US FAERS
16Back PainFAERS: 1US FAERS
17Disease recurrenceFAERS: 1US FAERS
18ErythemaFAERS: 1US FAERS
19HypersensitivityFAERS: 1US FAERS
20Inappropriate schedule of drug administrationFAERS: 1US FAERS
21Incorrect drug administration durationFAERS: 1US FAERS
22Incorrect product administration durationFAERS: 1US FAERS
23Incorrect route of drug administrationFAERS: 1US FAERS
24Incorrect route of product administrationFAERS: 1US FAERS
25InflammationFAERS: 1US FAERS
26MalaiseFAERS: 1US FAERS
27NauseaFAERS: 1US FAERS
28PainFAERS: 1US FAERS
29Product container issueFAERS: 1US FAERS
30Product prescribing errorFAERS: 1US FAERS
31Product selection errorFAERS: 1US FAERS
32Product use in unapproved indicationFAERS: 1US FAERS
33Skin irritationFAERS: 1US FAERS
34Skin lacerationFAERS: 1US FAERS
35ToothacheFAERS: 1US FAERS
36VomitingFAERS: 1US FAERS
37Wrong drug administeredFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.